These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36609356)

  • 21. A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.
    Seiler M; Staubli G; Hoeffe J; Gualco G; Manzano S; Goldman RD
    BMC Public Health; 2021 Jun; 21(1):1275. PubMed ID: 34193102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Near real-time observation reveals increased prevalence of young patients in the ICU during the emerging third SARS-CoV-2 wave in Switzerland.
    Hilty MP; Moser A; David S; Wendel Garcia PD; Capaldo G; Keiser S; Fumeaux T; Guerci P; Montomoli J; Van Boeckel TP; Jeitziner MM; Que YA; Jakob S; Schüpbach RA;
    Swiss Med Wkly; 2021 Jul; 151():. PubMed ID: 34291810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Bayesian spatio-temporal analysis of mortality rates in Spain: application to the COVID-19 2020 outbreak.
    Saavedra P; Santana A; Bello L; Pacheco JM; Sanjuán E
    Popul Health Metr; 2021 May; 19(1):27. PubMed ID: 34059063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance.
    Odone A; Delmonte D; Gaetti G; Signorelli C
    Public Health; 2021 Jan; 190():108-115. PubMed ID: 33412438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of disease transmission, mortality, and economic output over the first 2 years of the COVID-19 pandemic.
    Morgenstern C; Laydon DJ; Whittaker C; Mishra S; Haw D; Bhatt S; Ferguson NM
    PLoS One; 2024; 19(6):e0301785. PubMed ID: 38870106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan.
    Ng TC; Cheng HY; Chang HH; Liu CC; Yang CC; Jian SW; Liu DP; Cohen T; Lin HH
    JAMA Intern Med; 2021 Jul; 181(7):913-921. PubMed ID: 33821922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
    Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
    Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Excess Mortality and Household Income in Rural Bangladesh During the COVID-19 Pandemic in 2020.
    Barnwal P; Yao Y; Wang Y; Juy NA; Raihan S; Haque MA; van Geen A
    JAMA Netw Open; 2021 Nov; 4(11):e2132777. PubMed ID: 34779849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Comprehensive COVID-19 Testing Program Outcomes in a US Dental Clinical Care Academic Setting.
    Choi SE; Sima C; Colom LP; Nguyen GT; Giannobile WV
    JAMA Netw Open; 2022 Dec; 5(12):e2246530. PubMed ID: 36512355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
    Saeed S; O'Brien SF; Abe K; Yi QL; Rathod B; Wang J; Fazel-Zarandi M; Tuite A; Fisman D; Wood H; Colwill K; Gingras AC; Drews SJ
    PLoS One; 2021; 16(9):e0257743. PubMed ID: 34555095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
    Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland.
    Anderegg N; Althaus CL; Colin S; Hauser A; Laube A; Mäusezahl M; Wagner M; Zaffora B; Riou J
    Swiss Med Wkly; 2022 Apr; 152():w30163. PubMed ID: 35752951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the Overall Mortality during the COVID-19 Outbreak in the Provinces of Milan and Lodi (Lombardy Region, Northern Italy).
    Sandrini M; Andreano A; Murtas R; Tunesi S; Riussi A; Guido D; Greco MT; Gattoni ME; Gervasi F; Consolazio D; Adreoni L; Decarli A; Russo AG
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):244-251. PubMed ID: 33412816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland.
    Maung KK; Marques-Vidal P
    Open Heart; 2023 Mar; 10(1):. PubMed ID: 36977515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
    Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
    BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of SARS-CoV-2 on incidence, treatment and outcome of very preterm born infants in Switzerland: a retrospective, population-based cohort study.
    Adams M; Schulzke SM; Rogdo B; Meyer P; McDougall J; Stocker M; Schneider J; Riedel T; Pfister R; Bassler D;
    Swiss Med Wkly; 2022 May; 152():w30174. PubMed ID: 35748336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    COVID-19 Forecasting Team
    Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland.
    Chen C; Nadeau SA; Topolsky I; Manceau M; Huisman JS; Jablonski KP; Fuhrmann L; Dreifuss D; Jahn K; Beckmann C; Redondo M; Noppen C; Risch L; Risch M; Wohlwend N; Kas S; Bodmer T; Roloff T; Stange M; Egli A; Eckerle I; Kaiser L; Denes R; Feldkamp M; Nissen I; Santacroce N; Burcklen E; Aquino C; de Gouvea AC; Moccia MD; Grüter S; Sykes T; Opitz L; White G; Neff L; Popovic D; Patrignani A; Tracy J; Schlapbach R; Dermitzakis ET; Harshman K; Xenarios I; Pegeot H; Cerutti L; Penet D; Blin A; Elies M; Althaus CL; Beisel C; Beerenwinkel N; Ackermann M; Stadler T
    Epidemics; 2021 Dec; 37():100480. PubMed ID: 34488035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.